S 3762119th CongressIn Committee
Prior Authorization Relief Act
Standard Summary
Balanced plain-English summary
The Prior Authorization Relief Act amends the Social Security Act to reform prior authorization under Medicare Advantage. It requires the Secretary of HHS to audit high-reimbursement items, services, and Part D drugs that have sufficient clinical evidence and overly complex prior authorization steps, then issue a final rule standardizing prior authorization requirements across Medicare Advantage and MA-PD plans. It also exempts certain services furnished by providers in two-sided risk models, subject to a plan request process.
Key Points
- 1Requires an HHS audit by January 1, 2027, of Medicare Advantage prior authorization requirements for high-reimbursement items, services, and Part D drugs.
- 2Directs the Secretary to standardize prior authorization requirements across Medicare Advantage and MA-PD plans by May 1, 2028.
- 3Exempts identified items and drugs from prior authorization when furnished by providers participating in certain two-sided risk models.
- 4Allows Medicare Advantage organizations to request that the exemption not apply to their plan enrollees.
- 5Aims to reduce administrative complexity and streamline prior authorization processes.
Impact Areas
Medicare Advantage enrolleesMedicare Advantage and MA-PD plansProviders and suppliersAccountable care organizations and risk-based model participantsHHS and CMS
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026